BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4601594)

  • 1. Effect of immunosuppression and lung transplantation upon surfactant.
    Drews JA; Tierney DF; Benfield JR
    Surgery; 1974 Jul; 76(1):80-7. PubMed ID: 4601594
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation of the lung: a symposium. Lung grafting and surfactant.
    Benfield JR; Drews JA; Shors E
    Vasc Surg; 1974; 8(5):298-304. PubMed ID: 4376316
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of cigarette smoke on incorporation of radioisotopically labeled palmitic acid into pulmonary surfactant and on surface activity of canine lung extracts.
    Giammona ST; Tocci P; Webb WR
    Am Rev Respir Dis; 1971 Sep; 104(3):358-67. PubMed ID: 5110043
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
    Gelfand MC; Nowakowski A; Friedman EA; Knepshield JH
    Transplantation; 1971 Nov; 12(5):377-83. PubMed ID: 4948689
    [No Abstract]   [Full Text] [Related]  

  • 5. The action of paraquat on the incorporation of palmitic acid into dipalmitoyl lecithin in mouse lungs.
    Fletcher K; Wyatt I
    Br J Exp Pathol; 1972 Apr; 53(2):225-30. PubMed ID: 5067714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of immunosuppressive agents and matching on pulmonary allografts.
    Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
    Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular dynamics and lipid metabolism in the lung.
    Naimark A
    Fed Proc; 1973 Sep; 32(9):1967-71. PubMed ID: 4740780
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial ECG voltage and clearance times of 99mTc-labeled albumin in heterotopic canine heart allografts.
    Moore TC; Johnson DE; Cleveland RJ
    J Thorac Cardiovasc Surg; 1974 Sep; 68(3):419-23. PubMed ID: 4604805
    [No Abstract]   [Full Text] [Related]  

  • 9. A new functional test for transplanted lungs.
    Vuillard P; Gadot P; Danjou-Ravier MA; Radice PA; Belleville J; Falconnet J; Lesbroc F; Lamothe PX; Descoted J
    Eur Surg Res; 1970; 2(1):34-40. PubMed ID: 4950490
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histological and immunological aspects of rejection of homotransplanted lungs (author's transl)].
    Radaszkiewicz T; Keiler A; Salem G; Göber I; Kreuzer W
    Wien Klin Wochenschr; 1974 May; 86(10):272-6. PubMed ID: 4611038
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary allografts in the dog: function the first year.
    Karlson KE; Garzon AA; Paley N; Motlagh F; Dutta S; O'Kadigwe C
    Bull Soc Int Chir; 1972; 31(4):272-6. PubMed ID: 4561450
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of surfactant by lung allograft extracts.
    Drews JA; Tierney DF; Benfield JR
    J Thorac Cardiovasc Surg; 1974 Nov; 68(5):837-41. PubMed ID: 4607672
    [No Abstract]   [Full Text] [Related]  

  • 13. Preservation of pulmonary surfactant activity in canine lung allografts by immune suppressive therapy.
    Thomas PA; Jolly PC
    J Thorac Cardiovasc Surg; 1968 Mar; 55(3):405-10. PubMed ID: 4868266
    [No Abstract]   [Full Text] [Related]  

  • 14. Canine lung allografts during rejection.
    Benfield JR; Isawa T; Castagna J; White P; Gondos B
    Bull Soc Int Chir; 1972; 31(4):277-82. PubMed ID: 4561451
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of oxygen inhibition of pulmonary surfactant synthesis.
    Gilder H; McSherry CK
    Surgery; 1974 Jul; 76(1):72-9. PubMed ID: 4407725
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary surfactant and dog lung transplant.
    Prevost MC; Berthoumieux F; Douste-Blazy L; Eschapasse H
    Biomedicine; 1977 Mar; 27(2):78-81. PubMed ID: 324532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urethan-induced pulmonary adenoma as a tool for the study of surfactant biosynthesis.
    Snyder C; Malone B; Nettesheim P; Snyder F
    Cancer Res; 1973 Oct; 33(10):2437-43. PubMed ID: 4800231
    [No Abstract]   [Full Text] [Related]  

  • 18. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328
    [No Abstract]   [Full Text] [Related]  

  • 19. Early metabolic alterations in renal allografts.
    O'Brien JP; Harlan WR; White HJ
    Am J Physiol; 1970 Mar; 218(3):714-8. PubMed ID: 4905481
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.